MLSS
Price
$0.25
Change
-$0.02 (-7.41%)
Updated
Feb 4 closing price
Capitalization
19.96M
50 days until earnings call
Intraday BUY SELL Signals
STXS
Price
$2.09
Change
-$0.09 (-4.13%)
Updated
Feb 4 closing price
Capitalization
195.05M
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MLSS vs STXS

Header iconMLSS vs STXS Comparison
Open Charts MLSS vs STXSBanner chart's image
Milestone Scientific
Price$0.25
Change-$0.02 (-7.41%)
Volume$132.86K
Capitalization19.96M
Stereotaxis
Price$2.09
Change-$0.09 (-4.13%)
Volume$814K
Capitalization195.05M
MLSS vs STXS Comparison Chart in %
MLSS
Daily Signal:
Gain/Loss:
STXS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MLSS vs. STXS commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLSS is a StrongBuy and STXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (MLSS: $0.25 vs. STXS: $2.09)
Brand notoriety: MLSS and STXS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MLSS: 33% vs. STXS: 154%
Market capitalization -- MLSS: $19.96M vs. STXS: $195.05M
MLSS [@Pharmaceuticals: Other] is valued at $19.96M. STXS’s [@Pharmaceuticals: Other] market capitalization is $195.05M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $169.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLSS’s FA Score shows that 0 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • MLSS’s FA Score: 0 green, 5 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, STXS is a better buy in the long-term than MLSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLSS’s TA Score shows that 3 TA indicator(s) are bullish while STXS’s TA Score has 5 bullish TA indicator(s).

  • MLSS’s TA Score: 3 bullish, 5 bearish.
  • STXS’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, STXS is a better buy in the short-term than MLSS.

Price Growth

MLSS (@Pharmaceuticals: Other) experienced а -12.87% price change this week, while STXS (@Pharmaceuticals: Other) price change was -16.06% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.79%. For the same industry, the average monthly price growth was -0.75%, and the average quarterly price growth was +22.77%.

Reported Earning Dates

MLSS is expected to report earnings on Mar 27, 2026.

STXS is expected to report earnings on Feb 27, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-1.79% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STXS($195M) has a higher market cap than MLSS($20M). MLSS YTD gains are higher at: -6.996 vs. STXS (-9.130). MLSS has higher annual earnings (EBITDA): -6.49M vs. STXS (-22.57M). STXS has more cash in the bank: 10.5M vs. MLSS (1.35M). MLSS has less debt than STXS: MLSS (1.05M) vs STXS (5.58M). STXS has higher revenues than MLSS: STXS (30.1M) vs MLSS (8.93M).
MLSSSTXSMLSS / STXS
Capitalization20M195M10%
EBITDA-6.49M-22.57M29%
Gain YTD-6.996-9.13077%
P/E RatioN/AN/A-
Revenue8.93M30.1M30%
Total Cash1.35M10.5M13%
Total Debt1.05M5.58M19%
FUNDAMENTALS RATINGS
MLSS vs STXS: Fundamental Ratings
MLSS
STXS
OUTLOOK RATING
1..100
6579
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
99100
PRICE GROWTH RATING
1..100
9177
P/E GROWTH RATING
1..100
10060
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MLSS's Valuation (98) in the Medical Specialties industry is in the same range as STXS (99). This means that MLSS’s stock grew similarly to STXS’s over the last 12 months.

MLSS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as STXS (100). This means that MLSS’s stock grew similarly to STXS’s over the last 12 months.

MLSS's SMR Rating (99) in the Medical Specialties industry is in the same range as STXS (100). This means that MLSS’s stock grew similarly to STXS’s over the last 12 months.

STXS's Price Growth Rating (77) in the Medical Specialties industry is in the same range as MLSS (91). This means that STXS’s stock grew similarly to MLSS’s over the last 12 months.

STXS's P/E Growth Rating (60) in the Medical Specialties industry is somewhat better than the same rating for MLSS (100). This means that STXS’s stock grew somewhat faster than MLSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MLSSSTXS
RSI
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
77%
Bullish Trend 22 days ago
77%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
MLSS
Daily Signal:
Gain/Loss:
STXS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BGI0.980.06
+6.52%
Birks Group
FTNT81.121.82
+2.30%
Fortinet
MOMO6.40-0.09
-1.39%
Hello Group
CELC107.59-3.41
-3.07%
Celcuity
ACB3.75-0.31
-7.64%
Aurora Cannabis

MLSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLSS has been loosely correlated with NXGL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MLSS jumps, then NXGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLSS
1D Price
Change %
MLSS100%
-4.55%
NXGL - MLSS
48%
Loosely correlated
-0.81%
STVN - MLSS
48%
Loosely correlated
+1.00%
SMTI - MLSS
47%
Loosely correlated
+0.92%
STXS - MLSS
42%
Loosely correlated
-4.13%
ZJYL - MLSS
39%
Loosely correlated
+1.45%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
-4.13%
SMTI - STXS
56%
Loosely correlated
+0.92%
STVN - STXS
45%
Loosely correlated
+1.00%
NXGL - STXS
44%
Loosely correlated
-0.81%
RVP - STXS
41%
Loosely correlated
+4.69%
EMBC - STXS
39%
Loosely correlated
+4.03%
More